Download
association studies to locate human disease genes n.
Skip this Video
Loading SlideShow in 5 Seconds..
Association Studies To Locate Human Disease Genes PowerPoint Presentation
Download Presentation
Association Studies To Locate Human Disease Genes

Association Studies To Locate Human Disease Genes

355 Views Download Presentation
Download Presentation

Association Studies To Locate Human Disease Genes

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Association Studies To Locate Human Disease Genes Wentian Li, Ph.D The Robert S Boas Center for Genomics and Human Genetics North Shore LIJ Institute for Medical Research March 08, 2005

  2. GENE PHENOTYPE/DISEASEENVIRONMENT

  3. Linkage disequilibrium GENETIC MARKERGENEPHENOTYPE/DISEASEENVIRONMENT (controlled, fixed)

  4. Early history of association analysis (1921) blood type (ABO) and disease association JA Buchanan, ET Higley (1921) "The relationship of blood groups to disease", British Journal of Experimental Pathology 2:247-255.

  5. Early history of association analysis (1945) The suggestion to use ABO blood type/secretor polymorphism to detect association with diseases EB Ford (1945), "Polymorphism", Biological Reviews, 20:73-88.

  6. Early history of association analysis (1953-54) Ian Aird, HH Bentall, JA Fraser-Roberts (1953), "A relationship between cancer of stomach and the ABO blood groups",British Medical Journal, 1:799-801. I Aird, HH Bentall, JA Mehigan, JAF Roberts (1954), "The blood groups in relation to peptic ulceratiuon and carcinoma of the colon, rectum, breast and bronchus: an association between the ABO groups and peptic ulceration",British Medical Journal, 2:315-321.

  7. Early history of association analysis (1960s) • Polymorphism in Human Leukocyte Antigen (HLA) system (also known as Major Histocompatibility (MHC)) and disease association • International Histocompatibility Workshop (first one in 1964)

  8. Divergence between linkage and association analysis for human disease gene detection (1970s-1980s?) • Both are based on the same principle that the genetic polymorphism (itself may not have function) and the disease gene (it has function) lie close to each other on the chromosome. • Only the techniques are different • Association (and linkage disequilibrium) became mainly a topic in population genetics (with the exception of HLA-disease association analysis)

  9. Differences between linkage analysis and association analysis • Linkage analysis is based on pedigree data • Association analysis is based on population data • Linkage analyses rely on recombination events “in action” • Association analyses rely on ancestral recombinations • The statistic is linkage analysis is to count the number of recombinants and non-recombinants • The statistical method for association analysis is “statistical correlation”

  10. The domination of linkage analysis (1980s?) • The easy determination for restriction fragment length polymorphism (RFLP) made linkage analysis popular again • Linkage analysis helped to locate chromosomal regions for dozens of rare Mendelian diseases (in 1983, the first disease gene, for Huntington disease, was mapped ) • Even easier for typing and denser genetic marker: microsatellite markers

  11. Association analysis was brought back to disease mapping (1990s). I. Family-based association • The most often criticized aspect of association analysis, its inability to deal with population stratification, was thought to be solved by the family-based design • Genotype-based haplotype relative risk (Falk and Rubinstein, 1987) • Haplotype-based haplotype relative risk (Terwilliger and Ott, 1992) • McNemar test (Terwilliger and Ott, 1992), Transmission disequilibrium test (TDT) (Spielman, McGinnis, Ewen, 1993)

  12. Association analysis was brought back to disease mapping (1990s). II. Weaker signal in complex diseases • TDT is shown to be more “powerful” than the affected-sib identical-by-descent sharing method (a nonparametric linkage analysis) for complex diseases (diseases with lower genotypic relative risk) • N Risch, K Merikangas (1996), "The future of genetic studies of complex human diseases", Science, 273:1516-1517

  13. Unlikely to exist Effect Linkage analysis Association studies Very difficult Frequency Statistical genetic methods for disease gene identification

  14. Association studies • Association between risk factor and disease: risk factor is significantly more frequent among affected than among unaffected individuals • In genetic epidemiology: • Risk factors = alleles/genotypes/haplotypes

  15. Association studies • Candidate genes (functional or positional) • Fine mapping in linkage regions • Genome wide screen

  16. Candidate gene analysis • Direct analysis: • Association studies between disease and functional SNPs (causative of disease) of candidate gene

  17. TagSNP Candidate gene analysis • Indirect analysis: • Association studies between disease and “random” SNPs within or near candidate gene • Linkage Disequilibrium mapping

  18. Yes No Cases n11 n12 n1. Controls n21 n22 n2. n.1 n.2 n.. Case-control studies: 2test Risk factor contingency table Test of independence: 2=  (O-E)2 / E with 1 df

  19. Case-control studies: 2test 2x3 contingency table Genotypes AA Aa aa Cases nAA nAa naa N Controls mAA mAa maa M tAA tAa taa N+M Test of independence: 2=  (O-E)2 / E with 2 df

  20. Case-control studies: 2test 2x2 contingency table Alleles A a Cases nA na 2N Controls mA ma 2M tA ta 2(N+M) Test of independence: 2=  (O-E)2 / E with 1 df

  21. Hardy-Weinberg Equilibrium Biallelic locus: A, a genotypes AA, Aa, aa Allele frequencies: A P(A) = p a P(a) = q Genotype frequencies are in HWE if: AA P(AA) = p2 Aa P(Aa) = 2pq aa P(aa) = q2

  22. 1 3 2 1 6 HAPLOTYPES 1 5 9 1 7 4 9 1 6 2 9 1 7 1 2 2 7 1 2 6 1 4 7 1 1 8 1 8 1 4 1 0 1 0 Haplotypes GENOTYPES Locus 1 2 1 3 Locus 2 1 6 1 5 9 4 1 7 9 1 Identification of phase 6 2 9 1 7 2 1 2 1 2 7 6 1 4 1 7 1 8 1 8 4 1 Locus N 1 0 1 0

  23. Statistical significance of a correlation versus correlation strength • Statistical significance is usually measured by “p-value”: the probability for observing the same amount of correlation or more if the true correlation is zero. • Correlation strength can be measured by many many quantities: D, D’, r2… • Correlation strength between a marker and the disease status is usually measured by odd-ratio (OR) • The 95% confidence interval (CI) of OR contains both information on “strength” and “significance” • When the sample size is increased, typically the p-value can become even more significant, whereas OR usually stays the same (but 95% CI of OR becomes more narrow).

  24. Graphic representation of LD r2 D’ GOLD

  25. Main Issues in Association Analysis • The association is typically detected between a non-function marker and the disease, instead of the disease gene itself and the disease status. (“non-direct” role of the disease gene in association analysis) • When the disease (case) group and the normal (control) group both are a mixture of subpopulations with a different proportion of mixing, even markers not associated with the disease will exhibit spurious association (heterogeneity)

  26. Zondervan & Cardon, 2004

  27. Solution to the first issue • Choose the marker, haplotype,… to have a matching (allele, haplotype,… ) frequency as the disease gene. • Whenever possible, typing a marker that is also functional (e.g. “coding SNP”, “functional SNP”, “regulatory SNP”)

  28. Association due to population stratification Marchini et al, 2004

  29. Well-known problem when case/control groups consist of two different subpopulations with different mixing proportion • Example: comparing people’s height between two places: 1. prison, and 2. nurse school • In prison, maybe 80% are men • In nursing school, maybe 80% are women • Men are on average taller than women • People in prison are taller than people in nurse school But the cause of this difference is due to the different mixing proportions, not due to “staying in prison makes people taller”

  30. Solution to the second issue • Try to use people from the same population in both case and control group. • Use neutral marker to test whether subpopulations exist • If possible use an isolated population (the extra benefit is to reduce the heterogeneity in the case group) • Use family-based association design (the disadvantage is that it is more costly, and parents of late-onset patients are hard to find)

  31. Lee et al. Gene and Immunity (2005)

  32. dis.e.qui.lib.ri.um, n. Loss or lack of stability or equilibrium link.age, n. (genetics) An association between two or more genes such that the traits they control tend to be inherited together. as.so.ci.a.tion, n. 1. The act of associating or the state of being associated. cor.re.la.tion, n. (statistics) the simultaneous change in value of two numerically valued random variables: ASSOCITION IS THE LEAST RIGOROUSLY DEFINED WORD!

  33. Criswell et al. Am J Hum Genetics (2005)